Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17498-17506
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17498
Table 3 Comparison of copy number alterations by array-based comparative genomic hybridization in recurrent regions in primary tumors and metastases n (%)
Recurrent regionPrimary tumorMetastasesAll tumors
n371148
Gains
01q21.3-q224 (10.8)1 (9.1)5 (10.4)
03q244 (10.8)0 (0)4 (8.3)
06p22.2-p22.19 (24.3)4 (36.4)13 (27.1)
07p21.3-p21.26 (16.2)3 (27.3)9 (18.8)
07q21.11-q21.122 (5.4)3 (27.3)5 (10.4)
08q24.34 (10.8)1 (9.1)5 (10.4)
09q34.116 (16.2)3 (27.3)9 (18.8)
11q13.1-q13.22 (5.4)2 (18.2)4 (8.3)
16p11.22 (5.4)3 (27.3)5 (10.4)
16q22.15 (13.5)1 (9.1)6 (12.5)
17p13.17 (18.9)3 (27.3)10 (20.8)
18q12.15 (13.5)0 (0)5 (10.4)
19p13.34 (10.8)0 (0)4 (8.3)
22q13.331 (2.7)2 (18.2)3 (6.3)
Losses
08q24.33 (8.1)0 (0)3 (6.3)
11q13.1-q13.22 (5.4)0 (0)2 (4.2)
16p11.22 (5.4)0 (0)2 (4.2)
16q22.11 (2.7)0 (0)1 (2.1)
17p13.11 (2.7)0 (0)1 (2.1)
22q13.330 (0)1 (9.1)1 (2.1)